Angina News and Research

Angina is chest pain or discomfort that occurs when an area of your heart muscle doesn't get enough oxygen-rich blood. Angina may feel like pressure or squeezing in your chest. The pain also may occur in your shoulders, arms, neck, jaw, or back. It can feel like indigestion.

NHLBI-supported research shares new strategies on hypertension, heart defect and air pollution

20. November 2009 05:00

New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18. [More]

83b4f6bc-d647-4da4-a307-6824cf566729|0|.0

Posted in: Medical Condition News | Healthcare News

Tags: Ace Inhibitor, Anemia, Angina, Angiotensin, Atherosclerosis, Blood Pressure, Blood Transfusion, Blood Vessel, Cardiology, Cardiovascular Disease, Congenital Heart Defect, Dentistry, Diabetes, Diet, Education, Exercise, Health and Human Services, Heart Failure, Hospital, Metabolic Syndrome, Obesity, Physiology, Pollution, Sleep, Smoking, Stroke, Transplant, Ultrasound, Weight Loss

Data from second positive pivotal study of PSD502 for treatment of PE presented

20. November 2009 00:52

At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora")., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). [More]

d813dc78-c992-4259-a39a-c277c8bdb0c2|0|.0

Posted in: Men's Health News | Drug Trial News

Tags: Allergy, Angina, Asthma, Cancer, Cholesterol, Cystitis, Diabetes, Erectile Dysfunction, Incontinence, Interstitial Cystitis, Metabolic Syndrome, New Drug Application, Overactive Bladder, Pediatrics, Premature Ejaculation, Sexual Dysfunction, Stress, Type 2 Diabetes, Urinary Incontinence

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

19. November 2009 08:36

At the annual meeting of the Sexual Medicine Society of North America, Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC, today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). [More]

a70e4e7a-e1ac-4c00-9287-42a28bd3aa55|0|.0

Posted in: Men's Health News | Drug Trial News

Tags: Allergy, Angina, Asthma, Cancer, Cholesterol, Cystitis, Diabetes, Erectile Dysfunction, Incontinence, Interstitial Cystitis, New Drug Application, Overactive Bladder, Pediatrics, Premature Ejaculation, Stress, Type 2 Diabetes

New Drug Application for ticagrelor submitted to FDA

19. November 2009 02:50

AstraZeneca today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome (ACS). [More]

4c85bed9-d3d8-4fcf-be2a-fb835b46dd63|0|.0

Posted in: Pharmaceutical News

Tags: Adenosine, Angina, Aspirin, Cardiology, Clopidogrel, Neuroscience, New Drug Application, Oncology, Plavix, Prasugrel

CRESTOR reduces major cardiovascular events in women by 46%

18. November 2009 05:05

A new analysis of the JUPITER trial, released today at the American Heart Association meeting in Orlando, Florida, demonstrates that CRESTOR (rosuvastatin calcium) 20mg reduced first major cardiovascular events by 46%. [More]

c902b942-aa3a-42cb-aa84-2bbe56fad227|0|.0

Posted in: Medical Condition News | Women's Health News | Pharmaceutical News

Tags: Angina, Atherosclerosis, Breast Cancer, Calcium, Cancer, Cardiology, Cardiovascular Disease, Cholesterol, Coronary Heart Disease, Diet, Lipoprotein, Neuroscience, Oncology, Rosuvastatin, Smoking, Statin, Stroke

First gene expression test for coronary artery disease

18. November 2009 02:03

The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain. [More]

32d390fb-9758-43f6-bfab-6a8e1a11d0ef|0|.0

Posted in: Device / Technology News | Medical Condition News | Healthcare News

Tags: Angina, Cardiology, Cardiovascular Disease, Coronary Artery Disease, Education, Gene Expression, Heart Failure, Oncology, Stenosis

Report on the U.S. cardiac surgery devices market

18. November 2009 01:46

In 2008, the U.S. market for cardiac surgery devices was valued at over $1.6 billion, representing growth of nearly 7% over 2007. [More]

0ef47999-29e6-406b-a3c8-625feca3dd2a|0|.0

Posted in: Device / Technology News

Tags: Angina, Atrial Fibrillation, Coronary Artery Disease, Radiofrequency Ablation, Transplant, Xenograft

Transplanting people's own stem cells into heart muscle lessens pain and improves ability to walk

18. November 2009 01:17

The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells. [More]

964b7626-dcb8-426f-a797-3220f6d28deb|0|.0

Posted in: Medical Procedure News | Medical Condition News

Tags: Angina, Angioplasty, Cell, Exercise, Hospital, Stem Cell, Transplant

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

16. November 2009 11:25

NovaDel Pharma Inc. today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned subsidiary of Hi-Tech Pharmacal Co., Inc. to commercialize and manufacture ZolpiMist™ in the United States and Canada. ZolpiMist™ is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008. [More]

5bd0c514-1bf9-4ac9-ad2a-c8b75ab5b65d|0|.0

Posted in: Pharmaceutical News

Tags: Angina, Biotechnology, Diabetes, Insomnia, Metabolism, Migraine, Nausea, Sleep

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

16. November 2009 10:43

Sciele Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd. and Addrenex Pharmaceuticals, Inc., a privately-held U.S. pharmaceutical company specializing in developing drugs that regulate the adrenergic system, today announced that Sciele has agreed to acquire Addrenex. [More]

79e82316-5308-4bc8-b395-d7e3b3286ce9|0|.0

Posted in: Business / Finance

Tags: Allergy, Angina, Asthma, Cancer, Cholesterol, Dermatology, Diabetes, New Drug Application, Pediatrics, Type 2 Diabetes

Aspirin doses have beneficial effects for patients with heart diorders: Study

16. November 2009 05:36

On Sunday, November 15, 2009, Florida Atlantic University (FAU) researcher Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science will present at the American Heart Association's Annual Scientific Sessions meeting in Orlando, FL, the first data in humans to show that all doses of aspirin used in clinical practice increase nitric oxide. [More]

b40736ff-c980-475c-bb62-73ea89fdddf1|1|5.0

Posted in: Drug Trial News | Medical Condition News

Tags: Angina, Aspirin, Blood Clot, Blood Vessel, Education, Nitric Oxide, Nursing, Stroke

Many heart attack patients have high levels of cardiac biomarkers in blood after leaving hospital

16. November 2009 04:14

Many heart attack patients have high levels of cardiac biomarkers in the blood for several months after leaving the hospital, with more shortness of breath and chest pain, according to a Henry Ford Hospital study. [More]

cabfd8ae-c72b-4af1-95b4-7ccb9f70c4fc|0|.0

Posted in: Medical Science News | Medical Condition News

Tags: Angina, Biomarker, Heart Failure, Hospital

Financial results for third-quarter 2009 announced by PLC Systems

11. November 2009 00:11

PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today reported financial results for the three and nine month periods ended September 30, 2009. [More]

b1dcab36-63a5-4460-83b4-aa036bf0bb98|0|.0

Posted in: Business / Finance

Tags: Angina

NIH grants $1 million to study whether Transcendental Meditation can prevent future heart attacks in CHD patients

7. November 2009 00:01

The National Institutes of Health's National Heart, Lung, and Blood Institute will fund a $1 million collaborative study by the Center for Natural Medicine and Prevention at Maharishi University of Management Research Institute and Columbia University Medical Center to determine whether the stress-reducing Transcendental Meditation technique can help patients with coronary heart disease (CHD) prevent future heart attacks, strokes and death. [More]

39f16cdb-b2fe-45c9-a3ed-769eccaa832e|2|5.0

Posted in: Medical Condition News

Tags: Angina, Angioplasty, Arrhythmia, Atherosclerosis, Cardiology, Coronary Artery Disease, Coronary Heart Disease, Education, Exercise, Insulin, Insulin Resistance, Meditation, Stress

USPTO issues Notice of Allowance to NovaDel Pharma

6. November 2009 01:01

NovaDel Pharma Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715, entitled “Buccal, Polar and Non-polar Spray Containing Zolpidem,” which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaMist™ Oral Spray spray technology. [More]

12c44673-26f9-4585-b95f-d9bccc025435|0|.0

Posted in: Business / Finance | Medical Patent News | Pharmaceutical News

Tags: Ambien, Amnesia, Angina, Biotechnology, Headache, Insomnia, Metabolism, Migraine, Nausea, Sleep

<< Previous posts

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Angina News and Research

NHLBI-supported research shares new strategies on hypertension, heart defect and air pollution

Data from second positive pivotal study of PSD502 for treatment of PE presented

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

New Drug Application for ticagrelor submitted to FDA

CRESTOR reduces major cardiovascular events in women by 46%

First gene expression test for coronary artery disease

Report on the U.S. cardiac surgery devices market

Transplanting people's own stem cells into heart muscle lessens pain and improves ability to walk

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Aspirin doses have beneficial effects for patients with heart diorders: Study

Many heart attack patients have high levels of cardiac biomarkers in blood after leaving hospital

Financial results for third-quarter 2009 announced by PLC Systems

NIH grants $1 million to study whether Transcendental Meditation can prevent future heart attacks in CHD patients

USPTO issues Notice of Allowance to NovaDel Pharma

Recent Articles

Free!

Recent Comments

Twitter

Information

Angina News and Research

Medical News Cloud

Recent Articles